2025 is a big year for Enliven. We are focused on clinical execution and preparing for the potential start of a pivotal trial for ELVN-001 in 2026. Watch for updated data from our Ph1a/b trial of ELVN-001 (ENABLE) in #CML in mid-2025. Learn more: https://bit.ly/3FoEYbG
Enliven Therapeutics
Biotechnology Research
Discovering and developing next generation precision oncology therapeutics
About us
Enliven Therapeutics is a biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer live not only longer, but better. Enliven aims to address existing and emerging unmet needs with a precision oncology approach that improves survival and enhances overall patient well-being. Enliven’s discovery process combines deep insights from clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.
- Website
-
http://www.enliventherapeutics.com
External link for Enliven Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Boulder, CO
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Precision Medicine, Small Molecule Targeted Therapies, and Oncology
Locations
-
Primary
Get directions
Boulder, CO, US
Employees at Enliven Therapeutics
Updates
-
Enliven Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update: https://bit.ly/3FoEYbG
-
-
Happy #EmployeeAppreciationDay to the dedicated Enliven team! Thank you to our employees who work hard to help people with cancer to not only live longer, but live better.
-
We are excited to be at the European Society of Hematology Conference on #CML in Vienna! Stop by our booth to learn about our ELVN-001 program and the ongoing ENABLE trial.
-
-
We look forward to participating in the TD Cowen 45th Annual Healthcare Conference on March 4. Read more here: https://bit.ly/41cNQsh #TDCowenHealthcare
-
-
Today, we proudly celebrate International Day for Women and Girls in Science – a day to honor the incredible contributions of women scientists and inspire future generations to pursue their dreams in STEM fields. We are proud to have many smart and talented women on our team working to address cancer’s unmet needs. #WomeninSTEM
-
-
On World Cancer Day, we stand united with patients, families, and healthcare professionals in our shared mission to transform the lives of those affected by cancer. At Enliven Therapeutics, our passion is to help people with cancer not only live longer, but live better. #WorldCancerDay #AdvancingMedicine #RestoringLives #PrecisionOncology
-
-
We are excited to be in San Francisco this week, meeting with investors and discussing the work we’re doing to help people with cancer to not only live longer, but live better. #JPM2025
-
-
2024 was a transformative year for Enliven as we shared two positive data updates from the Ph 1 trial evaluating ELVN-001 in CML (https://bit.ly/3ZEyLQX). We look forward to carrying this momentum into the new year and wish everyone a wonderful holiday season!
-